The Neuroscience Report—Vol. 15 (August 10, 2015): Antipsychotic Medications
Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks.
Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information.
Volume 15 (August 10, 2015): Antipsychotic Medications
Journal Articles
Rationale for Iloperidone in the Treatment of Posttraumatic Stress Disorder
Pseudoephedrine for the Treatment of Clozapine-Induced Incontinence
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
The Role of Long-acting Injectable Antipsychotics in Schizophrenia: A Critical Appraisal
News Articles
Positive Preclinical Results and Patent Allowed for Aequus’ Once-Weekly Transdermal Aripiprazole
Otsuka, Lundbeck bag blockbuster FDA approval for antipsychotic Rexulti
Antipsychotic Use Rising Among Teens and Young Adults
New Analysis of Smoking and Schizophrenia Suggests Causal Link
FDA Approves Invega Trinza, Four-times-a-year Treatment for Schizophrenia
Wildcards
Quantifying Clinical Relevance
Summer and Antipsychotics in the City
A History of the Ice Pick Lobotomy
Have a “supafly” week!
Category: Psychiatry, Psychopharmacology, Schizophrenia, The Neuroscience Report
